Tag Archives: Hemopurifier

Aethlon Medical, Inc, a therapeutic medical device and technology company focused on unmet needs in global health, announced today that it has received..

Aethlon Medical, Inc, a therapeutic technology company focused on unmet needs in global health and biodefense, announced today that it has received an Expedited Access Pathway (EAP) designation from the United States Food and Drug Administration (FDA) to support the ...

SAN DIEGO, Nov. 6, 2014 /PRNewswire/ — Aethlon Medical, Inc. (NASDAQ: OTCQB:AEMD), the pioneer in developing targeted therapeutic devices to address infectious disease and cancer, announced today that officials at Frankfurt University Hospital have reported undetectable virus in an ebola ...

SAN DIEGO, Oct. 14, 2014 /PRNewswire/ — Aethlon Medical, Inc. (NASDAQ: OTCQB:AEMD), announced today the first use of Hemopurifier® therapy on a patient infected with Ebola virus.  The treatment was administered to a Ugandan doctor at the Frankfurt University Hospital ...

AN DIEGO, Aug. 6, 2014 /PRNewswire/ — Aethlon Medical, Inc. (OTCQB: AEMD), today released the following note authored by its Chairman and CEO, Jim Joyce. The current ebola outbreak in West Africa demonstrates the urgent need for therapeutic strategies to ...

SAN DIEGO, Feb. 26, 2014 /PRNewswire/ — Aethlon Medical, Inc. (OTCQX:AEMD), the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and other life-threatening conditions, announced today that that it has reached an agreement in principle with DaVita ...

from Wall Street Cheat Sheet The molecular diagnostics industry is going through a flash point, with valuations being determined by Wall Street as new technologies are reshaping the landscape of the industry. The worldwide market for molecular testing was $3.7 ...